AshfordD.A.GomezT.M.NoahD.L.ScottD.P., & FranzD.R. (2000). Biological terrorism and veterinary medicine in the United States. Journal of American Veterinary Medical Association, 217(5), 664–667.
2.
BryanJ.L. & FieldsH.F. (1999). An ounce of prevention is worth a pound of cure—shoring up the public health infrastructure to respond to bioterrorist attacks. American Journal of Infection Control, 27(6), 465–467.
3.
BurrowsW.D., & RennerS.E. (1999). Biological warfare agents as threats to potable water. Environmental Health Perspectives, 107(12), 975–984.
4.
ChristopherG.W.CieslakT.J.TheodoreJ.PauvlinJ.A., & EitzenE.M. (1997). Biological warfare: A historical perspective. Journal of American Medical Association, 278, 412–417.
5.
ClarkeR.A. (1999). Finding the right balance against bioterrorism. Emerging Infectious Disease, 5(4), 497.
6.
ColeL.A. (1996). The specter of biological weapons. Scientific American, 275(6), 60–65.
7.
ColeL.A. (1999). Risks of publicity about bioterrorism: Anthrax hoaxes and hype. American Journal of Infection Control, 27(6), 470–473.
8.
DanzigR., & BerkowskyP.B. (1997). Why should we be concerned about biological warfare?Journal of American Medical Association, 278, 431–432.
9.
DixonT.C.MeselsonM.GuilleminJ., & HannaP.C. (1999). Medical progress: Anthrax. The New England Journal of Medicine, 341(11), 815–826.
10.
EitzenE.CulepepperR.CieslakT.ChristopherG.RoweJ., & KortepeterM. (Eds.). (1999). Medical management of biological casualties handbook (pp. 10–14, 40–44). Fort Detrick, MD: US Army Medical Research Institute of Infectious Diseases.
11.
FalkenrathR. (2000). Weapons of mass reaction. Harvard International Review, 22(2), 52–55.
12.
FranzD.R.JahrlingP.B.FriedlanderA.M.McClainD.J.HooverD.L.BryneW.R.PavlinJ.A.ChristopherG.W., & EitzenE.M. (1997). Clinical recognition and management of patients exposed to biological warfare agents. Journal of American Medical Association, 278(5), 399–411.
13.
FraserM.R., & BrownD.L. (2000). Bioterrorism preparedness and local public health agencies: Building response capacity. Public Health Reports, 115(4), 326–330.
14.
FriedlanderA.M.PittmanP.R., & ParkerG.W. (1999). Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax. Journal of American Medical Association, 282(22), 2104–2106.
15.
GarrettL. (2001). The nightmare of bioterrorism. Foreign Affairs, 80(1), 76–89.
16.
GeorgeC.W.CieslakT.J.PavlinJ. A., & EitzenE.M. (1997). Biological warefare: A historical perspective. Journal of American Medical Association, 278(5), 412–417.
17.
HagstadD., & KearneyK. (2000). Bioterrorism. American Journal of Nursing, 100(12), 33–35.
18.
HendersonD.A.InglesbyT.V.BartlettJ.G.AscherM.S.EitzenE.JahrlingP.B.HauerJ.LaytonM.McDadeJ.OsterholmM.T.O'TooleT.ParkerG.PerlT.RussellP.K., & TonatK. (1999). Smallpox as a biological weapon. Journal of American Medical Association, 281(22), 2127–2137.
19.
HoodE. (1999). Chemical and biological weapons: New questions, new answers. Environmental Health Perspectives, 107(12), 931–932.
20.
InglesbyT.V.HendersonD.A.BartlettJ.G.AscherM.S.FriedlanderA.M.JauerJ.McDadeJ.OsterholmM.T.O'TooleT.ParkerG.PerlT.M.RussellP.K., & TonatK. (1999). Anthrax as a biological weapon. Journal of American Medical Association, 281, 1735–1745.
21.
KadlecR.P.ZelicoffA.P., & VrtisA.M. (1997). Biological weapons control: Prospects and implications for the future. Journal of American Medical Association, 278(5), 351–356.
22.
KaufmannA.F.MeltzerM.I., & SchmidG.P. (1997). The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable?Emerging Infectious Diseases, 3(2), 83–94.
23.
KhanA.S.MorseS., & LillibridgeS. (2000). Public-health preparedness for biological terrorism in the USA. The Lancet, 356(9236), 1179–1182.
24.
KoplanJ. (2000, November). CDC's strategic plan for bioterrorism. Symposium conducted at the meeting of the Second National Symposium on Medical and Public Health Response to Bioterrorism, Public Health Emergency and National Security Threat, Washington, DC.
25.
KrenzelokE.P.AllswedeA.P., & MrvosR. (2000). The poison center role in biological and chemical terrorism. Vetinary Human Toxicology, 42(5), 297–300.
26.
LillibridgeS.R.BellA.J., & RomanR.S. (1999). Centers for Disease Control and Prevention bioterrorism preparedness and response. American Journal of Infection Control, 27(6), 463–464.
27.
MacintyreA.G.ChristopherG.W.EitzenE.M.GumR.WeirS.DeAtleyC.TonatK., & BarberaJ.A. (2000). Weapons of mass destruction events with contaminated casualties: Effective planning for health care facilities. Journal of the American Medical Association, 283(2), 242–249.
SimonJ.D. (1997). Biological terrorism: Preparing to meet the treat. Journal of the American Medical Association, 278(5), 428–430.
39.
SlaterM.S., & TrunkeyD.D. (1997). Terrorism in America. Archives of Surgery, 132(10), 1059–1066.
40.
TorokT.J.TauxeR.V.WiseR.P.LivengoodJ.R.SokolowR.MauvaisS.BirknessK.A.SkelsM.R.HoranJ.M., & FosterL.R. (1997). A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. Journal of the American Medical Association, 278(5), 389–395.
41.
TuckerJ.B. (1999). Historical trends related to bioterrorism: An empirical analysis. Emerging Infectious Diseases, 5(4), 498–504.
42.
TuckerJ.B. (2000). Chemical and biological terrorism: How real a threat?Current History, 99(636), 147–153.
43.
WithersM.R., & ChristopherG.W. (2000). Aeromedical evacuation of biological warfare casualties: A treatise on infectious diseases on aircraft. Military Medicine, 165(Suppl. 3), 1–21.